The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?
Freedom Leaf
OCTOBER 15, 2018
On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). If you enjoyed this Freedom Leaf article, subscribe to the magazine today! Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.
Let's personalize your content